JPMorgan Chase & Co’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.11M | Buy |
256,443
+85,653
| +50% | +$369K | ﹤0.01% | 3671 |
|
2025
Q1 | $639K | Buy |
170,790
+152,376
| +828% | +$570K | ﹤0.01% | 3891 |
|
2024
Q4 | $187K | Sell |
18,414
-73,968
| -80% | -$750K | ﹤0.01% | 4555 |
|
2024
Q3 | $1.15M | Buy |
92,382
+7,325
| +9% | +$91.2K | ﹤0.01% | 3570 |
|
2024
Q2 | $1.11M | Sell |
85,057
-6,782
| -7% | -$88.3K | ﹤0.01% | 3453 |
|
2024
Q1 | $2.08M | Buy |
91,839
+13,098
| +17% | +$297K | ﹤0.01% | 3132 |
|
2023
Q4 | $1.02M | Buy |
78,741
+2,666
| +4% | +$34.6K | ﹤0.01% | 3515 |
|
2023
Q3 | $1.53M | Buy |
76,075
+70,113
| +1,176% | +$1.41M | ﹤0.01% | 3167 |
|
2023
Q2 | $160K | Sell |
5,962
-6,749
| -53% | -$181K | ﹤0.01% | 4398 |
|
2023
Q1 | $742K | Sell |
12,711
-86,100
| -87% | -$5.03M | ﹤0.01% | 3615 |
|
2022
Q4 | $5.04M | Buy |
98,811
+86,863
| +727% | +$4.43M | ﹤0.01% | 2366 |
|
2022
Q3 | $978K | Sell |
11,948
-330
| -3% | -$27K | ﹤0.01% | 3378 |
|
2022
Q2 | $830K | Sell |
12,278
-35,631
| -74% | -$2.41M | ﹤0.01% | 3591 |
|
2022
Q1 | $5.3M | Sell |
47,909
-1,651
| -3% | -$183K | ﹤0.01% | 2523 |
|
2021
Q4 | $4.78M | Buy |
49,560
+18,565
| +60% | +$1.79M | ﹤0.01% | 2613 |
|
2021
Q3 | $2.71M | Sell |
30,995
-1,220
| -4% | -$106K | ﹤0.01% | 2975 |
|
2021
Q2 | $4.99M | Buy |
32,215
+9,565
| +42% | +$1.48M | ﹤0.01% | 2643 |
|
2021
Q1 | $3.58M | Buy |
22,650
+318
| +1% | +$50.2K | ﹤0.01% | 2875 |
|
2020
Q4 | $5.19M | Buy |
22,332
+1,066
| +5% | +$248K | ﹤0.01% | 2405 |
|
2020
Q3 | $4.65M | Buy |
21,266
+3,187
| +18% | +$697K | ﹤0.01% | 2259 |
|
2020
Q2 | $5.14M | Buy |
18,079
+897
| +5% | +$255K | ﹤0.01% | 2133 |
|
2020
Q1 | $4.95M | Sell |
17,182
-6,650
| -28% | -$1.92M | ﹤0.01% | 2012 |
|
2019
Q4 | $6.85M | Buy |
23,832
+9,518
| +66% | +$2.74M | ﹤0.01% | 2001 |
|
2019
Q3 | $2.07M | Buy |
14,314
+630
| +5% | +$90.9K | ﹤0.01% | 2713 |
|
2019
Q2 | $1.26M | Sell |
13,684
-218
| -2% | -$20K | ﹤0.01% | 2930 |
|
2019
Q1 | $1.22M | Buy |
13,902
+6,070
| +78% | +$532K | ﹤0.01% | 2929 |
|
2018
Q4 | $1.1M | Sell |
7,832
-290
| -4% | -$40.8K | ﹤0.01% | 2987 |
|
2018
Q3 | $2.08M | Buy |
8,122
+19
| +0.2% | +$4.85K | ﹤0.01% | 2770 |
|
2018
Q2 | $2.07M | Sell |
8,103
-11,188
| -58% | -$2.85M | ﹤0.01% | 2796 |
|
2018
Q1 | $3.88M | Sell |
19,291
-662
| -3% | -$133K | ﹤0.01% | 2367 |
|
2017
Q4 | $2.87M | Sell |
19,953
-527
| -3% | -$75.9K | ﹤0.01% | 2558 |
|
2017
Q3 | $3.34M | Buy |
20,480
+18,081
| +754% | +$2.95M | ﹤0.01% | 2395 |
|
2017
Q2 | $326K | Sell |
2,399
-32,175
| -93% | -$4.37M | ﹤0.01% | 3272 |
|
2017
Q1 | $6.66M | Buy |
34,574
+7,082
| +26% | +$1.36M | ﹤0.01% | 1931 |
|
2016
Q4 | $3.88M | Buy |
27,492
+2,559
| +10% | +$361K | ﹤0.01% | 2317 |
|
2016
Q3 | $3.64M | Buy |
24,933
+801
| +3% | +$117K | ﹤0.01% | 2174 |
|
2016
Q2 | $2.43M | Buy |
24,132
+5,452
| +29% | +$549K | ﹤0.01% | 2362 |
|
2016
Q1 | $2.5M | Buy |
18,680
+4,198
| +29% | +$562K | ﹤0.01% | 2283 |
|
2015
Q4 | $2.88M | Buy |
14,482
+9,119
| +170% | +$1.81M | ﹤0.01% | 2215 |
|
2015
Q3 | $846K | Sell |
5,363
-242
| -4% | -$38.2K | ﹤0.01% | 2753 |
|
2015
Q2 | $2.29M | Buy |
5,605
+2,438
| +77% | +$995K | ﹤0.01% | 2456 |
|
2015
Q1 | $1.45M | Sell |
3,167
-153
| -5% | -$70.2K | ﹤0.01% | 2663 |
|
2014
Q4 | $1.86M | Sell |
3,320
-317
| -9% | -$178K | ﹤0.01% | 2528 |
|
2014
Q3 | $1.91M | Buy |
3,637
+82
| +2% | +$43K | ﹤0.01% | 2459 |
|
2014
Q2 | $2.48M | Sell |
3,555
-1,208
| -25% | -$844K | ﹤0.01% | 2353 |
|
2014
Q1 | $2.21M | Sell |
4,763
-2,476
| -34% | -$1.15M | ﹤0.01% | 2455 |
|
2013
Q4 | $2.49M | Buy |
+7,239
| New | +$2.49M | ﹤0.01% | 2422 |
|